InvestorsHub Logo
Followers 89
Posts 6835
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 38805

Saturday, 03/11/2023 8:59:04 AM

Saturday, March 11, 2023 8:59:04 AM

Post# of 43316
Thanks for yet another informative article, Chaplain. I thought this was interesting:

"It's not entirely clear how the rats contracted SARS-CoV-2 or whether they pose a particular danger to human health.

But theoretically, the fact that they can catch the virus from people means they can pass it back, according to researchers. This would be a particular concern if, say, they incubated a highly contagious vaccine-resistant variant.

Other animals have contracted the SARS-CoV-2 virus from people, including deer, otters, ferrets, hamsters, gorillas, cats, dogs, lions and tigers. Millions of farm-raised mink were killed early in the pandemic to prevent them from infecting people."

https://www.yahoo.com/news/another-reason-avoid-rodents-nycs-160438992.html

But also of interest to me was the information about Eiger's interferon lambda, which was embedded as a link in your article.

"The fact that interferon lambda was able to reduce hospitalization among vaccinated people, who are less likely to have a severe outcome, shows the value of the drug, Sax said...

Data from the newly published study has been available for nearly a year and Sax said he thought the drug would have been approved long ago...

But the Food and Drug Administration determined that the study was not adequate to win authorization and said more data was needed. Eiger not yet managed to fund another COVID-19 trial.

Apelian said he hopes some countries, perhaps China and Australia, will authorize the drug shortly, allowing it to prove its usefulness."

https://www.usatoday.com/story/news/health/2023/02/08/covid-antiviral-interferon-lambda-shot/11199875002/

New Covid Treatments Face Uphill Battle for Clearance
Drugmaker Eiger says it won’t seek clearance for interferon
Study design creates confusion about findings, expert says
ByMadison Muller
February 8, 2023 at 4:10 PM CST

https://www.bloomberg.com/news/articles/2023-02-08/covid-19-therapy-study-revives-debate-over-lack-of-clearance?leadSource=uverify%20wall
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.